64 related articles for article (PubMed ID: 469636)
1. Paranodal vascular spread in breast cancer with axillary node involvement.
Hartveit F
J Pathol; 1979 Mar; 127(3):111-4. PubMed ID: 469636
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in breast cancer patients with tumour cells in the efferent vessels of their axillary nodes.
Hartveit F; Skjaerven R; Maehle BO
J Pathol; 1983 Mar; 139(3):379-82. PubMed ID: 6834179
[TBL] [Abstract][Full Text] [Related]
3. Paranodal tumour in breast cancer: extranodal extension versus vascular spread.
Hartveit F
J Pathol; 1984 Dec; 144(4):253-6. PubMed ID: 6520648
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
5. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
6. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
7. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
8. Node-positive breast cancer: axillary micrometastases, their incidence and some implications.
Hartveit F
Invasion Metastasis; 1996; 16(6):317-21. PubMed ID: 9371231
[TBL] [Abstract][Full Text] [Related]
9. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
11. The routine histological investigation of axillary lymph nodes for metastatic breast cancer.
Hartveit F
J Pathol; 1984 Jul; 143(3):187-91. PubMed ID: 6379134
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
13. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. The significance of one positive axillary node.
Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC
Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602
[TBL] [Abstract][Full Text] [Related]
16. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
17. [Identification of the sentinel node in patients with breast carcinoma].
Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369
[TBL] [Abstract][Full Text] [Related]
18. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
Naik R; Baliga P; Bansal R; Pai M
J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
Pierga JY; Mouret E; Diéras V; Laurence V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Vincent-Salomon A; Scholl S; Extra JM; Asselain B; Pouillart P
Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657
[TBL] [Abstract][Full Text] [Related]
20. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
